T. Rowe Price Associates »

Trevi Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $772k 65k 11.93
2025-12-31 $630k 50k 12.53
2025-09-30 $429k 47k 9.16
2025-06-30 $211k 39k 5.47
2025-03-31 $203k 32k 6.31
2024-12-31 $104k 25k 4.13
2024-09-30 $64k 19k 3.36
2024-06-30 $57k 19k 2.99
2024-03-31 $47k 14k 3.47